Chicago cancer-fighting firm Tempus raises $200M; company now valued at $3.1B

Tempus announced Thursday that it raised $200 million in a Series F round that values the Chicago startup at $3.1 billion.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.